SURFACE ONCOLOGY INC(NASDAQ:SURF) stock News

SURF Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Surface Oncology, Inc.

Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences

2 years ago - By: Surface Oncology, Inc. - Mentions: CHRS

Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences

2 years ago - By: Benzinga - Mentions: CHRS

Health Care Company Coherus BioSciences Announces Merger With Surface Oncology

2 years ago - By: Benzinga

Recap: Surface Oncology Q1 Earnings

2 years ago - By: Kahn Swick & Foti, LLC

SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF

2 years ago - By: Surface Oncology, Inc.

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023

2 years ago - By: Surface Oncology, Inc.

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023

2 years ago - By: Kahn Swick & Foti, LLC

SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF

2 years ago - By: BusinessInsider - Mentions: CHRS

Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Surface Oncology, Inc. has obtained a Fair Price in its transaction with Coherus

2 years ago - By: Halper Sadeh LLC

SURF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surface Oncology, Inc. Is Fair to Shareholders

2 years ago - By: Surface Oncology, Inc. - Mentions: CHRS

Coherus to Acquire Surface Oncology

2 years ago - By: Surface Oncology, Inc.

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023

2 years ago - By: Surface Oncology, Inc.

Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023

2 years ago - By: Surface Oncology, Inc.

Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023

2 years ago - By: Surface Oncology, Inc.

Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022

2 years ago - By: Surface Oncology, Inc.

SURFACE ONCOLOGY INC (SURF) Stock News

SURF Latest News, Press Relases and Analysis

Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences

Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences

Health Care Company Coherus BioSciences Announces Merger With Surface Oncology

Recap: Surface Oncology Q1 Earnings

SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023

SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF

Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability

Shareholder Alert: Ademi LLP investigates whether Surface Oncology, Inc. has obtained a Fair Price in its transaction with Coherus

SURF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surface Oncology, Inc. Is Fair to Shareholders

Coherus to Acquire Surface Oncology

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023

Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023

Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023

Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022

Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference